Celofos 1 gm Injection

Get a Price/Quote

MOQ : 10 Pieces

Celofos 1 gm Injection Specification

Indication
Treatment of various cancers including testicular cancer and other solid tumors

Pacakaging (Quantity Per Box)
Single dose vial

Life Span
Refer to expiry on packaging

Brand Name
Celofos 1000

Origin of Medicine
India

Packaging Type
Box with vial(s)

Dosage Form
Powder for injection with separate mesna solution

Salt Composition
Ifosfamide 1 gm, Mesna Injection

Drug Type
Cytotoxic / Anticancer

Ingredients
Ifosfamide, Mesna

Physical Form
Injection

Function

Recommended For
Cancer Treatment

Dosage
As directed by the physician

Dosage Guidelines
Administer as prescribed by oncologist or healthcare professional

Suitable For
Adults

Quantity
1 gm

Storage Instructions
Store in a cool and dry place, protect from light

Appearance
White to off-white powder with clear mesna solution

Box Contents
One vial of Ifosfamide 1 gm and one ampoule of mesna injection

Warning
To be administered under guidance of qualified oncologist only

Route of Administration
Intravenous injection

Prescription Status
Prescription only (Rx)

Regulatory Compliance
Complies with IP standards (Indian Pharmacopoeia)

Country of Approval / Export
Available in Canada, Europe, UK, USA, Australia

Reconstitution Instructions
To be reconstituted with suitable solvent by healthcare professional

Celofos 1 gm Injection About

Jump on the latest breakthrough with Celofos 1 gm Injection-a valiant masterpiece in cancer treatment. This astonishing prescription-only medication, developed in India and meeting IP standards, delivers powerful anti-neoplastic action through its cytotoxic composition of Ifosfamide (1 gm) and Mesna. Its administration is strictly intravenous, intended for use under the guidance of a qualified oncologist. Order today and secure a single dose vial (with mesna ampoule), and join patients across Canada, UK, USA, Europe, and Australia benefiting from its proven efficacy. Store in cool, dry places and refer to packaging for expiry.

Celofos 1 gm Injection: Precision for Cancer Care

Celofos 1 gm Injection stands out as a cutting-edge solution for various cancers, including testicular and other solid tumors. Specifically designed for administration via intravenous injection, it features a unique blend of Ifosfamide and Mesna. Its anti-neoplastic function makes it particularly suitable for adult patients requiring valiant therapeutic efforts. The medicine arrives as a white to off-white powder, reconstituted by professionals, ensuring exact delivery for maximum efficacy.

Celofos 1 gm Injection: Lowest Price, Express Shipping

Celofos 1 gm Injection is available from India with convenient FOB port options and flexible payment terms. Sample availability for qualified buyers is provided, all at the lowest price point. Express shipping and secure packaging guarantee timely and safe delivery worldwide-including Canada, Europe, the UK, USA, and Australia. Trust in our secure shipping practices for maintaining medicine integrity from order to delivery.

FAQ's of Celofos 1 gm Injection:

Q: How is Celofos 1 gm Injection administered?

A: Celofos 1 gm Injection is administered intravenously by a healthcare professional, typically an oncologist, after proper reconstitution with a suitable solvent.

Q: What specific cancers does Celofos 1 gm Injection treat?

A: This medication is indicated for various cancers, including testicular cancer and other solid tumors, offering a targeted anti-neoplastic effect.

Q: When should Celofos 1 gm Injection be used?

A: Use Celofos 1 gm Injection strictly as prescribed by your oncologist, who will determine the correct timing and dosage based on your treatment plan.

Q: Where is Celofos 1 gm Injection available for export?

A: Celofos 1 gm Injection can be exported to Canada, UK, Europe, USA, and Australia, complying with international regulatory standards.

Q: What makes Celofos 1 gm Injection unique in cancer therapy?

A: It combines Ifosfamide and Mesna in a single package, ensuring efficacy with safety against toxicity, and is recognized as a regulatory-compliant, IP-standard therapy.